UBS Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,006
| Closed | -$55K | – | 10553 |
|
|
2022
Q2 | $55K | Buy |
+1,006
| New | +$55K | ﹤0.01% | 4841 |
|
|
2020
Q1 | – | Sell |
-1,435
| Closed | -$20K | – | 7368 |
|
|
2019
Q4 | $20K | Buy |
1,435
+461
| +47% | +$6.43K | ﹤0.01% | 5822 |
|
|
2019
Q3 | $15K | Buy |
974
+789
| +426% | +$12.2K | ﹤0.01% | 5958 |
|
|
2019
Q2 | $4K | Buy |
+185
| New | +$4K | ﹤0.01% | 6603 |
|
|
2019
Q1 | – | Sell |
-1,159
| Closed | -$61K | – | 7261 |
|
|
2018
Q4 | $61K | Sell |
1,159
-3,711
| -76% | -$195K | ﹤0.01% | 5045 |
|
|
2018
Q3 | $331K | Sell |
4,870
-714
| -13% | -$48.5K | ﹤0.01% | 3897 |
|
|
2018
Q2 | $661K | Buy |
5,584
+4,239
| +315% | +$502K | ﹤0.01% | 3363 |
|
|
2018
Q1 | $111K | Buy |
+1,345
| New | +$111K | ﹤0.01% | 4330 |
|
|
2017
Q4 | – | Sell |
-128
| Closed | -$8K | – | 7062 |
|
|
2017
Q3 | $8K | Buy |
+128
| New | +$8K | ﹤0.01% | 6104 |
|
|
2017
Q2 | – | Sell |
-73
| Closed | -$4K | – | 6952 |
|
|
2017
Q1 | $4K | Buy |
+73
| New | +$4K | ﹤0.01% | 6179 |
|
|
2016
Q3 | – | Sell |
-104
| Closed | -$8K | – | 6933 |
|
|
2016
Q2 | $8K | Buy |
+104
| New | +$8K | ﹤0.01% | 6022 |
|
|
2015
Q4 | – | Sell |
-10
| Closed | -$8K | – | 7064 |
|
|
2015
Q3 | $8K | Buy |
+10
| New | +$8K | ﹤0.01% | 6061 |
|